Maruoka K, Yamanaka M, Misago M, Nakata K, Tsukada J, Nagata K, Sato T, Mori N, Oda S, Chiba S
Rinsho Ketsueki. 1989 Jul;30(7):988-93.
We investigated serum acid and alkaline RNase activities in 16 cases of acute crisis of chronic myelocytic leukemia (CML), 21 cases of untreated CML, and 13 cases of treated CML, to clarify clinical significance of the determination of RNase activities in acute crisis of CML. We obtained results as follows; the ratio of acid to alkaline Rnase activities (Ac/Al ratio) of chronic phase of CML was 1.64 +/- 0.47 (mean +/- SD) in the untreated cases, and was 1.32 +/- 0.16 in the treated cases. The Ac/Al ratio always indicated over 1.0 in the chronic phase of CML without any relationship to treatments. On the other hand, in the cases of acute crisis, the Ac/Al ratio was significantly lowered (0.94 +/- 0.22) as compared to the chronic phase of CML (p less than 0.001), and was similar to that of acute leukemia. The acid and alkaline RNase activities of the blast from the patients with acute crisis of CML showed remarkably lower value than those of leukemic cells from patients with chronic phase of CML. Therefore, it was Suggested that the return to normal range of Ac/Al ratio in acute crisis of CML depended on marked decrease of RNase activities of blasts. Thus, serial determinations of the enzyme activities are considered to be one of useful tools for prediction of acute crisis of CML.
我们研究了16例慢性粒细胞白血病(CML)急性发作期患者、21例未经治疗的CML患者和13例接受治疗的CML患者的血清酸性和碱性核糖核酸酶活性,以阐明CML急性发作期核糖核酸酶活性测定的临床意义。我们得到以下结果:未经治疗的CML慢性期患者酸性与碱性核糖核酸酶活性之比(Ac/Al比值)为1.64±0.47(均值±标准差),接受治疗的患者该比值为1.32±0.16。在CML慢性期,Ac/Al比值始终大于1.0,与治疗无关。另一方面,在急性发作期患者中,Ac/Al比值与CML慢性期相比显著降低(0.94±0.22)(p<0.001),与急性白血病患者相似。CML急性发作期患者原始细胞的酸性和碱性核糖核酸酶活性显著低于CML慢性期患者的白血病细胞。因此,提示CML急性发作期Ac/Al比值恢复正常范围取决于原始细胞核糖核酸酶活性的显著降低。因此,连续测定酶活性被认为是预测CML急性发作期的有用工具之一。